
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Thymic Function and T-Cell Receptor Repertoire Diversity: Implications for Patient Response to Checkpoint Blockade Immunotherapy
Antonella Cardinale, Carmen Dolores De Luca, Franco Locatelli, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 24
Antonella Cardinale, Carmen Dolores De Luca, Franco Locatelli, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 24
Showing 24 citing articles:
Evaluation of the TCR Repertoire as a Predictive and Prognostic Biomarker in Cancer: Diversity or Clonality?
Andrea Aran, Laia Garrigós, Giuseppe Curigliano, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1771-1771
Open Access | Times Cited: 41
Andrea Aran, Laia Garrigós, Giuseppe Curigliano, et al.
Cancers (2022) Vol. 14, Iss. 7, pp. 1771-1771
Open Access | Times Cited: 41
The Next Chapter in Immunotherapy and Radiation Combination Therapy: Cancer-Specific Perspectives
Amy J. Wisdom, Christopher A. Barker, Joe Y. Chang, et al.
International Journal of Radiation Oncology*Biology*Physics (2024) Vol. 118, Iss. 5, pp. 1404-1421
Closed Access | Times Cited: 11
Amy J. Wisdom, Christopher A. Barker, Joe Y. Chang, et al.
International Journal of Radiation Oncology*Biology*Physics (2024) Vol. 118, Iss. 5, pp. 1404-1421
Closed Access | Times Cited: 11
Progress and prospect of ASCT combined with CAR-T therapy in the treatment of multiple myeloma
S. Yuan, Ying Chen, Huasheng Liu
Therapeutic Advances in Hematology (2024) Vol. 15
Open Access | Times Cited: 6
S. Yuan, Ying Chen, Huasheng Liu
Therapeutic Advances in Hematology (2024) Vol. 15
Open Access | Times Cited: 6
Cancer Immunotherapy with Immune Checkpoint Inhibitors-Biomarkers of Response and Toxicity; Current Limitations and Future Promise
Brian Bird, Kenneth Nally, Karine Ronan, et al.
Diagnostics (2022) Vol. 12, Iss. 1, pp. 124-124
Open Access | Times Cited: 22
Brian Bird, Kenneth Nally, Karine Ronan, et al.
Diagnostics (2022) Vol. 12, Iss. 1, pp. 124-124
Open Access | Times Cited: 22
Differences in tumor-associated T-cell receptor repertoires between early-onset and average-onset colorectal cancer
Ya-Yu Tsai, Kanika G. Nair, Shimoli V. Barot, et al.
JNCI Journal of the National Cancer Institute (2024) Vol. 116, Iss. 10, pp. 1645-1653
Closed Access | Times Cited: 4
Ya-Yu Tsai, Kanika G. Nair, Shimoli V. Barot, et al.
JNCI Journal of the National Cancer Institute (2024) Vol. 116, Iss. 10, pp. 1645-1653
Closed Access | Times Cited: 4
Elucidating the Role of the T Cell Receptor Repertoire in Myelodysplastic Neoplasms and Acute Myeloid Leukemia
Georgios Petros Barakos, Vasileios Georgoulis, Epameinondas Koumpis, et al.
Diseases (2025) Vol. 13, Iss. 1, pp. 19-19
Open Access
Georgios Petros Barakos, Vasileios Georgoulis, Epameinondas Koumpis, et al.
Diseases (2025) Vol. 13, Iss. 1, pp. 19-19
Open Access
Paeonol inhibits melanoma growth by targeting PD1 through upregulation of miR-139-5p
Xianjie Chen, Zhenyuan Xu, Lu Meng, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 656, pp. 86-96
Open Access | Times Cited: 9
Xianjie Chen, Zhenyuan Xu, Lu Meng, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 656, pp. 86-96
Open Access | Times Cited: 9
Immune Microenvironment in Childhood Cancers: Characteristics and Therapeutic Challenges
Anup Singh Pathania
Cancers (2024) Vol. 16, Iss. 12, pp. 2201-2201
Open Access | Times Cited: 3
Anup Singh Pathania
Cancers (2024) Vol. 16, Iss. 12, pp. 2201-2201
Open Access | Times Cited: 3
Integrated analysis of single-cell and bulk transcriptome identifies a signature based on NK cell marker genes to predict prognosis and therapeutic response in clear cell renal cell carcinoma
Ke Wang, M. Y. Yu, Zhouzhou Zhang, et al.
Translational Cancer Research (2023) Vol. 12, Iss. 5, pp. 1270-1289
Open Access | Times Cited: 7
Ke Wang, M. Y. Yu, Zhouzhou Zhang, et al.
Translational Cancer Research (2023) Vol. 12, Iss. 5, pp. 1270-1289
Open Access | Times Cited: 7
Similar usage of T‐cell receptor β‐chain between tumor and adjacent normal tissue in hepatocellular carcinoma
Jiezuan Yang, Shaoyan Xu, Dangsheng Xiao, et al.
Cancer Medicine (2024) Vol. 13, Iss. 16
Open Access | Times Cited: 2
Jiezuan Yang, Shaoyan Xu, Dangsheng Xiao, et al.
Cancer Medicine (2024) Vol. 13, Iss. 16
Open Access | Times Cited: 2
Immune Diseases Associated with Aging: Molecular Mechanisms and Treatment Strategies
Mi Eun Kim, Jun Sik Lee
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15584-15584
Open Access | Times Cited: 6
Mi Eun Kim, Jun Sik Lee
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15584-15584
Open Access | Times Cited: 6
A Proposed Link Between Acute Thymic Involution and Late Adverse Effects of Chemotherapy
Maria Lagou, Dimitra P. Anastasiadou, George S. Karagiannis
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Maria Lagou, Dimitra P. Anastasiadou, George S. Karagiannis
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Comparison of oral zinc supplement and placebo effect in improving the T-cells regeneration in patients undergoing autologous hematopoietic stem cell transplantation: Clinical trial study
Maryam Nikoonezhad, Ahmad Zavaran Hosseini, Abbas Hajifathali, et al.
Medicine (2024) Vol. 103, Iss. 51, pp. e33170-e33170
Open Access | Times Cited: 1
Maryam Nikoonezhad, Ahmad Zavaran Hosseini, Abbas Hajifathali, et al.
Medicine (2024) Vol. 103, Iss. 51, pp. e33170-e33170
Open Access | Times Cited: 1
PTPRD/PTPRT mutation as a predictive biomarker of immune checkpoint inhibitors across multiple cancer types
Xiaoling Shang, Wengang Zhang, Xun Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
Xiaoling Shang, Wengang Zhang, Xun Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
Restored Thymic Output after Androgen Blockade Participates in Antitumor Immunity
Fanny Polesso, Breanna Caruso, Scott A. Hammond, et al.
The Journal of Immunology (2022) Vol. 210, Iss. 4, pp. 496-503
Open Access | Times Cited: 7
Fanny Polesso, Breanna Caruso, Scott A. Hammond, et al.
The Journal of Immunology (2022) Vol. 210, Iss. 4, pp. 496-503
Open Access | Times Cited: 7
Promise and Challenges of Checkpoint Inhibitor Therapy for Progressive Multifocal Leukoencephalopathy in HIV
Sydney Corey, Bryan Smith, Irene Cortese
Current HIV/AIDS Reports (2022) Vol. 19, Iss. 6, pp. 580-591
Open Access | Times Cited: 4
Sydney Corey, Bryan Smith, Irene Cortese
Current HIV/AIDS Reports (2022) Vol. 19, Iss. 6, pp. 580-591
Open Access | Times Cited: 4
Immunological Changes with Age and Innovative Approaches to Bolster Immune Function in Older Adults
Nkiruka Rose Ukibe, Chizoba Rita Dike, Augustine Chinedu Ihim, et al.
IDOSR JOURNAL OF SCIENTIFIC RESEARCH (2024) Vol. 9, Iss. 1, pp. 1-11
Open Access
Nkiruka Rose Ukibe, Chizoba Rita Dike, Augustine Chinedu Ihim, et al.
IDOSR JOURNAL OF SCIENTIFIC RESEARCH (2024) Vol. 9, Iss. 1, pp. 1-11
Open Access
Impaired Tissue Content of Iron and Zinc in Mice with Growing Hepatoma 22A and Its Correction with Zinc Sulfate Supplementation
Е. А. Zelenskyi, K. V. Rutto, Andrey S. Trulioff, et al.
Journal of Evolutionary Biochemistry and Physiology (2024) Vol. 60, Iss. 4, pp. 1562-1576
Closed Access
Е. А. Zelenskyi, K. V. Rutto, Andrey S. Trulioff, et al.
Journal of Evolutionary Biochemistry and Physiology (2024) Vol. 60, Iss. 4, pp. 1562-1576
Closed Access
T Cell Receptor Diversity, Cancer and Sex: Insights from 30,000 TCRβRepertoires
H. Jabran Zahid, Ruth Taniguchi, Marco Garcia Noceda, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
H. Jabran Zahid, Ruth Taniguchi, Marco Garcia Noceda, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Pediatric brain tumor patients display altered immune activation and reduced lymphopoiesis at the onset of disease
Marco Rosichini, Giada Del Baldo, Carmen Dolores De Luca, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access
Marco Rosichini, Giada Del Baldo, Carmen Dolores De Luca, et al.
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access
Treatment with the thymic polypeptide fraction Biomodulina T potentiates immune responses in older adults and cancer patients: an overview of the most recent studies
Danay Saavedra, Ana Laura A耖-Kour�Nuris Led髇, Tania Crombet, et al.
Deleted Journal (2024) Vol. 2, Iss. 1
Open Access
Danay Saavedra, Ana Laura A耖-Kour�Nuris Led髇, Tania Crombet, et al.
Deleted Journal (2024) Vol. 2, Iss. 1
Open Access
Alterations in tissue content of iron and zinc in mice bearing hepatoma 22a and their correction by zinc sulphate supplementation
Е. А. Zelenskyi, K. V. Rutto, Andrey S. Trulioff, et al.
Российский физиологический журнал им И М Сеченова (2024) Vol. 110, Iss. 7
Closed Access
Е. А. Zelenskyi, K. V. Rutto, Andrey S. Trulioff, et al.
Российский физиологический журнал им И М Сеченова (2024) Vol. 110, Iss. 7
Closed Access
Cancer Immunotherapy Biomarkers of Response and Toxicity; Current Limitations and Future Promise
Brian Richard Bird, Kenneth Nally, Karine Ronan, et al.
(2021)
Open Access | Times Cited: 1
Brian Richard Bird, Kenneth Nally, Karine Ronan, et al.
(2021)
Open Access | Times Cited: 1
Thymic expression of immune checkpoint molecules and their implication for response to immunotherapies
Breanna Caruso, Amy E. Moran
Trends in cancer (2023) Vol. 9, Iss. 8, pp. 666-678
Closed Access
Breanna Caruso, Amy E. Moran
Trends in cancer (2023) Vol. 9, Iss. 8, pp. 666-678
Closed Access